Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Next Deadline
151 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200602)
Due Date
June 02, 2026
Grace Period Ends
December 02, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 2, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Feb 24, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 24, 2025 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Feb 24, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 24, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 24, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 24, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 15, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Oct 18, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 28, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 28, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 2, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 2, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 17, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 17, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 13, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Feb 26, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 26, 2020 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Feb 26, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 13, 2020 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Feb 11, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 7, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 6, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 5, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 5, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 24, 2019 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Aug 30, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Aug 15, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 15, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 26, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 23, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 22, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 22, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 22, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 18, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemicals used in industry and science, in particular for use in biotechnology, pharmaceutics, medicine and veterinary medicine
Class 005
Pharmaceutical and veterinary preparations, namely, preparations for the prevention and treatment of proliferative diseases, cancers, infectious diseases, autoimmune diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines, namely, DNA-based and RNA-based vaccines, adjuvant preparations for use with vaccines, nucleic acids sequences, proteins, and chemical reagents for medical and veterinary purposes, protein conjugates, peptides featuring antibodies and tumour markers; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of proliferating diseases, cancers, infectious diseases, and autoimmune diseases, attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids; diagnostic reagents and diagnostic preparations for medical purposes
Class 042
Scientific research and development in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, in particular research and development in the field of medical and veterinary diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; scientific research and development of diagnostic methods and test processes; scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; scientific consultancy services in the field of research and development of therapies and medical preparations; providing of scientific expertise in the nature of scientific study and research in the field of medicine; scientific research and development for medical and veterinary purposes; conducting and evaluating medical and pharmaceutical studies, namely, testing, analysis and evaluation of goods/services of others to determine conformity with certification standards
Class 044
Medical services; providing medical care services and consultation related thereto; urgent medical care centers; pharmaceutical and medical consultancy; providing healthcare information and advisory services in the healthcare field; medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; medical and pharmaceutical consultation; all the aforesaid services other than in the field of bione therapy or other types of therapy combined with bione therapy
Additional Information
Design Mark
The mark consists of the stylized wording "BIONTECH".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
042
044